English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45279/58455 (77%)
造訪人次 : 2490117      線上人數 : 146
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63294


    題名: 以機器學習分析乳癌五年復發率及危險因子預測
    Analyzing Five-year Recurrence Rate of Breast Cancer and Predicting Risk Factors by Machine Learning
    作者: 徐芷葳
    HSU, CHIH-WEI
    貢獻者: 醫務管理學系碩士班
    簡文山
    關鍵詞: 乳癌復發;機器學習;風險預測
    Breast Cancer Recurrence;Machine Learning;Risk Prediction
    日期: 2023-06-20
    上傳時間: 2023-12-11 13:21:55 (UTC+8)
    摘要: 研究目的:本研究使用羅吉斯迴歸、支持向量機、決策樹、隨機森林、梯度提升及人工神經網路等人工智慧演算方法,預測可能導致乳癌復發的高危險因子,提供醫師或患者雙方更全面的參考資訊,降低患者再次復發的機會。

    研究方法:以病歷回溯性世代研究方式,收集2000年至2021年臺北醫學大學之臨床研究資料庫中7006位乳癌患者相關資料,利用六種機器學習之方式將所蒐集之樣本進行隨機分組,建構「疾病預測模型」,納入人口學變項、臨床表徵及治療方式等相關就醫資?,以準確率、敏感度、特異度、精確率、F1-score及ROC等效能衡量指標,選擇最準確的演算法,來預測乳癌復發的可能危險因子。

    研究結果:結果顯示,7006位乳癌患者中五年內復發為458人,復發率為6.54 %。在機器學習模型預測乳癌復發危險因子方面,外部驗證以「梯度提升」模型結果最佳,其準確率為0.77、敏感度為0.79、特異度為0.77、精確率為0.22、F1-score為0.34、AUC為0.82,具有良好的預測能力。根據最佳模型中所預測的變項相對重要性排序,「原癌症期別」為影響乳癌復發最重要的危險因子,其次為淋巴結狀態,血型則並列第三。醫療提供者可使用機器學習模型的預測結果作為參考,相信能幫助醫療提供者與病人在預後的治療或照護,改善患者的預後和生活品質,同時減少患者、家屬或照顧者心理層面的負擔。
    Objective: This study employs artificial intelligence algorithms such as logistic regression, support vector machines, decision trees, random forests, gradient boosting, and artificial neural networks to predict high-risk factors associated with breast cancer recurrence. The aim is to provide comprehensive reference information for both physicians and patients, thereby reducing the chances of cancer recurrence.

    Methods: Using a retrospective cohort study design, we collected relevant data from 7,006 breast cancer patients in the clinical research database of Taipei Medical University from 2000 to 2021. The collected samples were randomly divided into groups using six machine learning algorithms to construct a "disease prediction model." The model incorporated demographic variables, disease context, and treatment modalities as relevant medical data. Accuracy, sensitivity, specificity, precision, F1-score, and ROC were used as performance evaluation metrics to select the most accurate algorithm for predicting potential risk factors for breast cancer recurrence.

    Results: The results showed that out of the 7,006 breast cancer patients, a total of 458 individuals experienced a recurrence within five years, resulting in a recurrence rate of 6.54%. Regarding the prediction of risk factors for breast cancer recurrence using the machine learning models, external validation revealed that the "gradient boosting" model performed the best. It achieved an accuracy of 0.77, sensitivity of 0.79, specificity of 0.77, precision of 0.22, F1-score of 0.34, and AUC of 0.82, demonstrating good predictive capability. According to the relative importance ranking of variables predicted by the best model, the "primary cancer stage" is the most crucial risk factor affecting breast cancer recurrence, followed by lymph node involvement. Blood type is tied for the third most important factor. Healthcare providers can utilize the predictive results of machine learning models as a reference, which is believed to assist them in making informed decisions regarding the prognosis, treatment, and care of patients. This can ultimately lead to improved patient outcomes and quality of life. Additionally, the utilization of these models can help reduce the psychological burden on patients, their families, and caregivers by providing valuable insights and guidance throughout the healthcare journey.
    描述: 碩士
    指導教授:簡文山
    委員:魏慶國
    委員:張偉斌
    委員:簡文山
    資料類型: thesis
    顯示於類別:[醫務管理學系暨研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML74檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋